Luceome Biotechnologies

About:

Luceome Biotechnologies is an biotechnology company that uses assay technology for identification of drugs against kinases.

Website: https://www.luceome.com/

Top Investors: National Institutes of Health

Description:

Luceome Biotechnologies offers cell-based and in vitro kinase assay services for drug discovery using its hybrid split-luciferase technology. They provide assay solutions that are based on a technology platform that utilises luciferase fragment complementation.

Total Funding Amount:

$1.9M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Tucson, Arizona, United States

Founded Date:

2007-01-01

Contact Email:

info(AT)luceome.com

Founders:

Indraneel Ghosh

Number of Employees:

1-10

Last Funding Date:

2011-08-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai